Back

Activation of neutrophil extracellular trap formation in patients with heart failure and a preserved ejection fraction

20 May 2023 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Biomarkers definning pathophysiology and prognosis Heart Failure with Preserved Ejection Fraction (HFpEF) HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Mr Bart Johan Van Essen

University Medical Centre Groningen, Groningen (Netherlands (The))

6 More presentations in this session

Presentation thumbnail
Cardiac Troponin-T and heart failure risk in individuals with low natriuretic peptide levels and obesity: results from the PREVEND study
Doctor N. Suthahar (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Soluble transferrin receptor as a marker of tissue iron deficiency: impact on clinical outcomes in patients with heart failure without systemic iron deficiency or anaemia
Miss M. Ras Jimenez (Hospitalet De Llobregat, ES)
Abstract Slides Video
Presentation thumbnail
Combined post- and pre-capillary pulmonary hypertension in heart failure is associated with increased levels of biomarkers of fibrosis, vasoconstriction and angiogenesis
Professor A. Roussoulieres (Brussels, BE)
Abstract Slides Video
Presentation thumbnail
Transcriptomic profiling of circulating extracellular vesicles identifies UBALD2 as a novel biomarker of cardiorenal disease
Miss B. Losada Fuentenebro (Pamplona, ES)
Abstract Slides Video
Presentation thumbnail
Association between NT-proBNP changes and clinical outcomes in paediatric patients with heart failure due to systemic left ventricular systolic dysfunction: Insights from PANORAMA-HF
Doctor R. Shaddy (Los Angeles, US)
Abstract Slides Video

Access the full session

Session thumbnail
Biomarkers definning pathophysiology and prognosis
Video

The Event

Event poster

Heart Failure 2023

20 May - 23 May 2023
You may be interested in
thumbnail
Congress Presentation
Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.
thumbnail
Congress Presentation
Pharmacotherapy in HFpEF: where do cardiometabolic drugs fit in?
thumbnail
Congress Session
Clinical phenotypes of heart failure with preserved ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources